FTC Approves Final Order Preserving Future Competition in Generic Injectable Tuberculosis Drug Market
Date
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Akorn, Inc.’s acquisition of VersaPharm Inc. and its parent company, VPI Holdings Corp...